Attovia Therapeutics, Inc. (ATTO)

SEC filing

Attovia Therapeutics, Inc.

ATTO · CIK 2058707

4/A · Oct 8, 2026 · Chief Financial Officer Chan Steven was granted 140K Stock Option (Right to Buy)

4/A

Chief Financial Officer Chan Steven was granted 140K Stock Option (Right to Buy)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.